Hypotensive response to atrial natriuretic factor in conscious renal hypertensive beagles. 1987

K C Lee, and J A Rodzinski, and F J Bex, and R W Lappe, and R L Wendt

The hemodynamic responses to i.v. infusion of 0.3 and 0.6 microgram/kg per min of human atrial natriuretic factor (hANF [102-126]) in intact, conscious, one-kidney, perinephritic, hypertensive beagles were examined and compared with the responses in ganglionic-blocked dogs. Blood pressure and heart rate were not affected but plasma ANF-like immunoreactivity was increased by as much as 627%. After hexamethonium (20 mg/kg, i.v.) blockade, a dose-dependent hypotensive response of up to 29 mmHg with no change in heart rate was observed. It is concluded that the compensatory mechanisms of the neurally mediated baroreflex system masked the depressor actions of hANF.

UI MeSH Term Description Entries
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D008297 Male Males
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006584 Hexamethonium Compounds Compounds containing the hexamethylenebis(trimethylammonium) cation. Members of this group frequently act as antihypertensive agents and selective ganglionic blocking agents. Compounds, Hexamethonium
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D018738 Hexamethonium A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool. Depressin,Hexamethonium Bitartrate,Hexamethonium Bromide,Hexamethonium Chloride,Hexamethonium Dibromide,Hexamethonium Dibromide Dihydrate,Hexamethonium Dichloride Dihydrate,Hexamethonium Dihydroxide,Hexamethonium Diiodide,Hexamethonium Dimethylsulfate,Hexamethonium Diperchlorate,Hexamethonium Iodide,Hexamethonium Monotartrate,Hexonium,Bitartrate, Hexamethonium,Bromide, Hexamethonium,Chloride, Hexamethonium,Dibromide Dihydrate, Hexamethonium,Dibromide, Hexamethonium,Dichloride Dihydrate, Hexamethonium,Dihydrate, Hexamethonium Dibromide,Dihydrate, Hexamethonium Dichloride,Dihydroxide, Hexamethonium,Diiodide, Hexamethonium,Dimethylsulfate, Hexamethonium,Diperchlorate, Hexamethonium,Iodide, Hexamethonium,Monotartrate, Hexamethonium

Related Publications

K C Lee, and J A Rodzinski, and F J Bex, and R W Lappe, and R L Wendt
December 1988, European journal of pharmacology,
K C Lee, and J A Rodzinski, and F J Bex, and R W Lappe, and R L Wendt
April 1985, The American journal of physiology,
K C Lee, and J A Rodzinski, and F J Bex, and R W Lappe, and R L Wendt
September 1984, European journal of pharmacology,
K C Lee, and J A Rodzinski, and F J Bex, and R W Lappe, and R L Wendt
February 1988, Journal of developmental physiology,
K C Lee, and J A Rodzinski, and F J Bex, and R W Lappe, and R L Wendt
January 1985, Hypertension (Dallas, Tex. : 1979),
K C Lee, and J A Rodzinski, and F J Bex, and R W Lappe, and R L Wendt
January 1989, The Japanese journal of physiology,
K C Lee, and J A Rodzinski, and F J Bex, and R W Lappe, and R L Wendt
December 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
K C Lee, and J A Rodzinski, and F J Bex, and R W Lappe, and R L Wendt
July 1989, Hypertension (Dallas, Tex. : 1979),
K C Lee, and J A Rodzinski, and F J Bex, and R W Lappe, and R L Wendt
December 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
K C Lee, and J A Rodzinski, and F J Bex, and R W Lappe, and R L Wendt
February 1991, The American journal of physiology,
Copied contents to your clipboard!